Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Biodesix (BDSX) Net Margin (2019 - 2025)

Historic Net Margin for Biodesix (BDSX) over the last 7 years, with Q3 2025 value amounting to 41.92%.

  • Biodesix's Net Margin rose 166600.0% to 41.92% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.85%, marking a year-over-year increase of 165800.0%. This contributed to the annual value of 59.95% for FY2024, which is 437000.0% up from last year.
  • Per Biodesix's latest filing, its Net Margin stood at 41.92% for Q3 2025, which was up 166600.0% from 58.03% recorded in Q2 2025.
  • In the past 5 years, Biodesix's Net Margin registered a high of 21.6% during Q1 2021, and its lowest value of 238.21% during Q1 2022.
  • Its 5-year average for Net Margin is 107.16%, with a median of 91.44% in 2024.
  • In the last 5 years, Biodesix's Net Margin surged by 1722600bps in 2021 and then plummeted by -2166100bps in 2022.
  • Quarter analysis of 5 years shows Biodesix's Net Margin stood at 182.38% in 2021, then increased by 6bps to 171.13% in 2022, then soared by 63bps to 62.71% in 2023, then soared by 34bps to 41.12% in 2024, then fell by -2bps to 41.92% in 2025.
  • Its Net Margin was 41.92% in Q3 2025, compared to 58.03% in Q2 2025 and 60.26% in Q1 2025.